Titre : | Naltrexone and dysphoria: fact or myth ? |
Titre traduit : | (Naltrexone et dysphorie : réalité ou mythe ?) |
Auteurs : | K. MIOTTO ; M. McCANN ; J. BASCH ; R. RAWSON ; W. LING |
Type de document : | Périodique |
Année de publication : | 2002 |
Format : | 151-160 |
Note générale : |
American Journal on Addictions, 2002, 11, (2), 151-160 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés NALTREXONE ; SEVRAGE ; EFFET SECONDAIRE ; TROUBLES DE L'HUMEUR |
Résumé : |
ENGLISH : Naltrexone is an opiate antagonist used as a pharmacologic adjuvant for the treatment of opiate and alcohol addiction. It bas been hypothesized that naltrexone blocks the stress-response and well-being effects associated with opioid peptides. This raises the clinical concern that naltrexone may cause opioid, and nicotine studies to delermine if an association between naltrexone and dysphoria exists. These studies did not reveal dyspboria to be a serious side effect produced by naltrexone treatment. Additionals studies to evaluate long-term endocrine effects and antidepressant combination therapy are warranted. (Author' s abstract) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 60 |
Affiliation : |
UCLA Dept Psychiat. Biobehavioral Sci., 760 Westwood Plaza, Los Angeles, CA 90024 Etats-Unis. United States. |
Numéro Toxibase : | 206270 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil